Noninvasive intranasal stem cells and other therapeutic cells bypass the blood-brain barrier to target the CNS to treat Parkinson's disease, stroke, neonatal ischemia, hemorrhage, multiple sclerosis, brain tumors, TBI, Alzheimer's and other CNS disorders
treat brain tumors. This intranasal delivery, targeting and treatment technology can make stem cell treatments, practical for CNS disorders by eliminating the need for invasive neurosurgical implantation of cells…

